Haoxi Health Technology (HAO) Stock Price, News & Analysis

Company Overview

Haoxi Health Technology Limited (NASDAQ: HAO) is a China-based digital marketing services company. Through its operating subsidiaries, the company provides online advertising and marketing solutions primarily to businesses in the healthcare sector.

Its services include helping advertisers plan and place promotional campaigns on digital platforms, including short-video and other online media channels. Haoxi’s activities may also include developing advertising content, managing campaigns, and using digital marketing tools to help clients reach prospective customers.

The company is organized as a Cayman Islands holding company, while its operating activities are conducted primarily through subsidiaries in China. Its business is focused on serving advertisers in the Chinese market, with an emphasis on healthcare-related products and services.

Key Stats

• Today's Range: $1.75 to $1.75
• 50-Day Range: $1.60 to $3.41
• 52-Week Range: $1.60 to $4,352.00
• Volume: 2,407 shs
• Average Volume: 138,878 shs
• Market Capitalization: $663.92 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Haoxi Health Technology Stock Analysis - MarketRank™

Haoxi Health Technology scored higher than 8% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

Haoxi Health Technology has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Haoxi Health Technology has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

Haoxi Health Technology has a P/B Ratio of 0.04. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

13.31% of the float of Haoxi Health Technology has been sold short.

Short Interest Ratio / Days to Cover

Haoxi Health Technology has a short interest ratio ("days to cover") of 0.37, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Haoxi Health Technology has recently increased by 54.74%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Haoxi Health Technology does not currently pay a dividend.

Dividend Growth

Haoxi Health Technology does not have a long track record of dividend growth.

News and Social Media

• Score: 2.1 / 5
• News Sentiment: 0.41

News Sentiment

Haoxi Health Technology has a news sentiment score of 0.41. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.52 average news sentiment score of Communication Services companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Haoxi Health Technology this week, compared to 1 article on an average week.

Company Ownership

• Score: N/A
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Haoxi Health Technology insiders have not sold or bought any company stock.

Percentage Held by Institutions

Haoxi Health Technology has minimal institutional ownership at this time.

Company Calendar

• Today: 11/12/2026
• Fiscal Year End: 6/30/2027

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Communication Services
• Industry: Media
• Sub-Industry: Advertising
• Current Symbol: NASDAQ:HAO
• Previous Symbol: NASDAQ:HAO
• CIK: 1954594
• Web: www.haoximedia.com
• Phone: 86-10-13311587976
• Fax: N/A
• Employees: 28
• Year Founded: 2018

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 4.53
• Quick Ratio: 4.53

Sales & Book Value

• Annual Sales: $54.83 million
• Price / Sales: 0.01
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $48.78 per share
• Price / Book: 0.04

Miscellaneous

• Outstanding Shares: 366,000
• Free Float: N/A
• Market Cap: $663.92 thousand
• Optionable: N/A
• Beta: -0.98